These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 17381454)
1. Factors associated with a high tumour thickness in patients with melanoma. Baumert J; Plewig G; Volkenandt M; Schmid-Wendtner MH Br J Dermatol; 2007 May; 156(5):938-44. PubMed ID: 17381454 [TBL] [Abstract][Full Text] [Related]
2. Time trends in tumour thickness vary in subgroups: analysis of 6475 patients by age, tumour site and melanoma subtype. Baumert J; Schmidt M; Giehl KA; Volkenandt M; Plewig G; Wendtner C; Schmid-Wendtner MH Melanoma Res; 2009 Feb; 19(1):24-30. PubMed ID: 19430403 [TBL] [Abstract][Full Text] [Related]
3. Acral lentiginous melanoma: a clinicoprognostic study of 126 cases. Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L Br J Dermatol; 2006 Sep; 155(3):561-9. PubMed ID: 16911282 [TBL] [Abstract][Full Text] [Related]
4. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma. Hoersch B; Leiter U; Garbe C Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427 [TBL] [Abstract][Full Text] [Related]
5. Nodular melanomas: analysis of the casistic and relationship with thick melanomas and diagnostic delay. Betti R; Martino P; Vergani R; Gualandri L; Crosti C J Dermatol; 2008 Oct; 35(10):643-50. PubMed ID: 19017043 [TBL] [Abstract][Full Text] [Related]
6. Changes from mid-1980s to late 1990s among clinical and demographic correlates of melanoma thickness. Crocetti E; Carli P Eur J Dermatol; 2003; 13(1):72-5. PubMed ID: 12609787 [TBL] [Abstract][Full Text] [Related]
7. Melanoma in middle-aged and older men: a multi-institutional survey study of factors related to tumor thickness. Swetter SM; Johnson TM; Miller DR; Layton CJ; Brooks KR; Geller AC Arch Dermatol; 2009 Apr; 145(4):397-404. PubMed ID: 19380661 [TBL] [Abstract][Full Text] [Related]
8. Delay in the diagnosis of cutaneous melanoma: an analysis of 233 patients. Schmid-Wendtner MH; Baumert J; Stange J; Volkenandt M Melanoma Res; 2002 Aug; 12(4):389-94. PubMed ID: 12170189 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological analysis of 1571 cutaneous malignant melanomas in Valencia, Spain: factors related to tumour thickness. Nagore E; Oliver V; Botella-Estrada R; Moreno-Picot S; Guillén C; Fortea JM Acta Derm Venereol; 2006; 86(1):50-6. PubMed ID: 16585990 [TBL] [Abstract][Full Text] [Related]
10. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society. Buettner PG; Leiter U; Eigentler TK; Garbe C Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700 [TBL] [Abstract][Full Text] [Related]
11. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors. Lindholm C; Andersson R; Dufmats M; Hansson J; Ingvar C; Möller T; Sjödin H; Stierner U; Wagenius G; Cancer; 2004 Nov; 101(9):2067-78. PubMed ID: 15372475 [TBL] [Abstract][Full Text] [Related]
12. Thick melanoma: the problem continues. Tejera-Vaquerizo A; Mendiola-Fernández M; Fernández-Orland A; Herrera-Ceballos E J Eur Acad Dermatol Venereol; 2008 May; 22(5):575-9. PubMed ID: 18081751 [TBL] [Abstract][Full Text] [Related]
13. Disease progression in patients with thin cutaneous melanomas (tumour thickness < or = 0.75 mm): clinical and epidemiological data from the Tumour Center Munich 1977-98. Schmid-Wendtner MH; Baumert J; Eberle J; Plewig G; Volkenandt M; Sander CA Br J Dermatol; 2003 Oct; 149(4):788-93. PubMed ID: 14616371 [TBL] [Abstract][Full Text] [Related]
14. Acral lentiginous melanoma: histopathological prognostic features of 121 cases. Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173 [TBL] [Abstract][Full Text] [Related]
15. Thin primary cutaneous melanomas: associated detection patterns, lesion characteristics, and patient characteristics. Schwartz JL; Wang TS; Hamilton TA; Lowe L; Sondak VK; Johnson TM Cancer; 2002 Oct; 95(7):1562-8. PubMed ID: 12237926 [TBL] [Abstract][Full Text] [Related]
16. The role of circumstances of diagnosis and access to dermatological care in early diagnosis of cutaneous melanoma: a population-based study in France. Durbec F; Vitry F; Granel-Brocard F; Lipsker D; Aubin F; Hédelin G; Dalac S; Truchetet F; Michel C; Batard ML; Domissy-Baury B; Halna JM; Schmutz JL; Delvincourt C; Reuter G; Dalle S; Bernard P; Danzon A; Grange F Arch Dermatol; 2010 Mar; 146(3):240-6. PubMed ID: 20231493 [TBL] [Abstract][Full Text] [Related]
18. Malignant melanoma of the head and neck in Scotland: an eight-year analysis of trends in prevalence, distribution and prognosis. Cox NH; Jones SK; MacKie RM Q J Med; 1987 Aug; 64(244):661-70. PubMed ID: 3444872 [TBL] [Abstract][Full Text] [Related]
19. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study. Crocetti E; Mangone L; Lo Scocco G; Carli P Melanoma Res; 2006 Oct; 16(5):429-33. PubMed ID: 17013092 [TBL] [Abstract][Full Text] [Related]
20. Late recurrence (10 years or more) of malignant melanoma in south-east Germany (Saxony). A single-centre analysis of 1881 patients with a follow-up of 10 years or more. Hansel G; Schönlebe J; Haroske G; Wollina U J Eur Acad Dermatol Venereol; 2010 Jul; 24(7):833-6. PubMed ID: 20070457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]